Cleared Special

K003469 - EECP THERAPY SYSTEM, MODEL TS3

K003469 is an FDA 510(k) clearance for EECP THERAPY SYSTEM, manufactured by Vasomedical, Inc.. The device is a Class 2 Cardiovascular device with product code DRN cleared through the Special 510(k) pathway after a 28-day FDA review.

K003469 · Vasomedical, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2000
Decision
28d
Days
Class 2
Risk

K003469 is an FDA 510(k) clearance for the EECP THERAPY SYSTEM, MODEL TS3. Classified as Device, Counter-pulsating, External (product code DRN), Class II - Special Controls.

Submitted by Vasomedical, Inc. (Westbury, US). The FDA issued a Cleared decision on December 6, 2000 after a review of 28 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.5225 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Vasomedical, Inc. devices

FDA 510(k) Submission Details - K003469

510(k) Number K003469 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 08, 2000
Decision Date December 06, 2000
Days to Decision 28 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
97d faster than avg
Panel avg: 125d · This submission: 28d
Pathway characteristics
Modification to existing cleared device.

DRN Device Classification - Class 2, Special Controls

Product Code DRN Device, Counter-pulsating, External
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.5225
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DRN Device, Counter-pulsating, External

All 11
Devices cleared under the same product code (DRN) and FDA review panel - the closest regulatory comparables to K003469.
EXTERNAL COUNTERPULSATION DEVICE WITH SP02 MORNITORING
K130439 · Chongqing Psk Sci-Tech Development Co., Ltd. · Dec 2013
CARDIASSIST COUNTER PULSATION SYSTEM SERIES 4000/5000
K050172 · Cardiomedics, Inc. · Mar 2005
ACS MODEL NCP-2
K042413 · Applied Cardiac Systems · Dec 2004
NICORE MODEL ESP -1
K980937 · Nicore Equipment & Leasing, Inc. · Sep 2000
THE CIRCULATOR BOOT
K971026 · Circulator Boot Corp. · Aug 1997